Evidence map›Paper›PMID 36320513›Full record

ArticleRSC advances2022

Retraction: The PI3K/Akt and NF-κB signaling pathways are involved in the protective effects of

Jia-Yu Yang, Yu-Te Zhong, Wei-Nan Hao, Xiang-Xiang Liu, Qiong Shen, Yan-Fei Li, Shen Ren, Zi Wang, Wei Li, Li-Chun Zhao

Abstract readRetraction Notice
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jia-Yu YangCollege of Chinese Medicinal Materials, Jilin Agricultural University Changchun 130118 China liwei7727@126.com +86-431-84533304 +86-431-84533304.
Yu-Te ZhongCollege of Pharmacy, Guangxi University of Chinese Medicine Nanning 530200 China hyzlc@163.com.
Wei-Nan HaoCollege of Chinese Medicinal Materials, Jilin Agricultural University Changchun 130118 China liwei7727@126.com +86-431-84533304 +86-431-84533304.
Xiang-Xiang LiuCollege of Chinese Medicinal Materials, Jilin Agricultural University Changchun 130118 China liwei7727@126.com +86-431-84533304 +86-431-84533304.
Qiong ShenCollege of Chinese Medicinal Materials, Jilin Agricultural University Changchun 130118 China liwei7727@126.com +86-431-84533304 +86-431-84533304.
Yan-Fei LiCollege of Chinese Medicinal Materials, Jilin Agricultural University Changchun 130118 China liwei7727@126.com +86-431-84533304 +86-431-84533304.
Shen RenCollege of Chinese Medicinal Materials, Jilin Agricultural University Changchun 130118 China liwei7727@126.com +86-431-84533304 +86-431-84533304.
Zi WangCollege of Chinese Medicinal Materials, Jilin Agricultural University Changchun 130118 China liwei7727@126.com +86-431-84533304 +86-431-84533304.
Wei LiCollege of Chinese Medicinal Materials, Jilin Agricultural University Changchun 130118 China liwei7727@126.com +86-431-84533304 +86-431-84533304.
Li-Chun ZhaoCollege of Pharmacy, Guangxi University of Chinese Medicine Nanning 530200 China hyzlc@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This retracts the article DOI: 10.1039/D0RA00020E.].

Identifiers

PMID36320513
PMCPMC9540404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.